Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

lilly_corporate_hq

Lilly and Boehringer’s Jardiance diabetes drug reduces cardiovascular risks

August 21, 2015 Medical Communications, Research and Development Boehringer Ingelheim, Eli Lilly, diabetes drugs

Eli Lilly’s diabetes drug Jardiance (empagliflozin) has shown in a study to be the very first blood sugar lowering drug …
News
sun_pharma_hq

Sun Pharma gets FDA approval for acne treatment

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing Sun Pharma. acne treatments, drug approvals

The FDA has approved Sun Pharma’s new acne treatment, Ximino.The Ximino (minocycline hydrochloride) extended-release capsules, which will be available in …
News
Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …
News
Sprout sign

FDA approves ‘female viagra’

August 19, 2015 Research and Development, Sales and Marketing Addyi, FDA, HSDD, Sprout, Sprout Pharmaceuticals, flibanserin, hypoactive sexual desire disorder

The FDA has approved Sprout Pharmaceuticals’ Addyi, a controversial libido-enhancing drug for women that has been dubbed the ‘female viagra’. …
News
BioScience Nottingham

Nottingham receives go ahead for new £30m life science facility

August 19, 2015 Manufacturing and Production, Research and Development BioCity Nottingham, R&D

Hundreds of pharma jobs are expected to be created in Nottingham after the construction of a new £30 million life …
News

Confronting the ‘danger’ of blocking progress on clinical trial transparency

August 19, 2015 Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

The Ethical Medicines Industry Group and Sense About Science – a co-founder of the ALLTrials campaign – have written a …
Feature

HRA must continue ‘progress towards clinical trial transparency’

August 19, 2015 Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

Campaigners and industry leaders have urged the Health Research Authority to ensure that its work to bring about full transparency …
News
car_t-cells

Kite Pharma says trial death was unrelated to KTE-C19

August 18, 2015 Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma

Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …
News
ALS research

Biogen collaborates with ALSA and Columbia University on genomic-based ALS treatments

August 18, 2015 Research and Development

Biogen, the ALS Association and Columbia University Medical Center (CUMC) have announced a new collaboration aimed at better understanding the differences …
News
Chest x ray

Roche lung cancer therapy succeeds in mid-stage trial

August 17, 2015 Research and Development, Sales and Marketing Genentech, Roche, atezolizumab, lung cancer, non-small cell lung cancer

Roche’s biotech arm Genentech has scored positive results in a pivotal Phase II study of its investigational cancer immunotherapy atezolizumab. …
News
Keytruda image

Merck in immuno-oncology collaboration with major cancer research centre

August 14, 2015 Research and Development Cancer, Merck, keytruda, oncology

Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …
News

Abbvie and Roche report success in Phase II leukaemia trial

August 13, 2015 Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax

AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …
News
contrave

Orexigen and Takeda reboot Contrave collaboration

August 12, 2015 Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs

Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …
News
Novavax

Novavax rides high on crest of RSV vaccine wave

August 12, 2015 Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines

The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …
News
MedImmune building

MedImmune and Inovio collaborate on cancer vaccine

August 11, 2015 Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology

MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026